Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 12833650)

Published in Curr Opin Investig Drugs on May 01, 2003

Authors

Christopher Pargellis1, John Regan

Author Affiliations

1: Department of Immunology/Inflammation Chemistry, Boehringer Ingelheim Pharmaceuticals Research and Development Center, 900 Ridgebury Road, Ridgefield, CT 06877, USA. cpargell@rdg.Boehringer-Ingelheim.com

Articles citing this

Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol Cell Biol (2005) 2.19

Molecular basis of MAPK-activated protein kinase 2:p38 assembly. Proc Natl Acad Sci U S A (2007) 1.40

Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis. Proc Natl Acad Sci U S A (2006) 1.37

Tumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivo. Arthritis Res Ther (2005) 1.01

Modulation of host cell signaling pathways as a therapeutic approach in periodontal disease. J Appl Oral Sci (2012) 0.93

Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS. PLoS One (2013) 0.90

Update on Targets of Biologic Therapies for Rheumatoid Arthritis. Curr Rheumatol Rev (2008) 0.89

MAPK usage in periodontal disease progression. J Signal Transduct (2012) 0.88

Distinct roles of Smad pathways and p38 pathways in cartilage-specific gene expression in synovial fibroblasts. J Clin Invest (2004) 0.86

Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice. Arthritis Res Ther (2009) 0.85

Induction of macrophage migration inhibitory factor in ConA-stimulated rheumatoid arthritis synovial fibroblasts through the P38 map kinase-dependent signaling pathway. Korean J Intern Med (2010) 0.80

Cyclic compression-induced p38 activation and subsequent MMP13 expression requires Rho/ROCK activity in bovine cartilage explants. Inflamm Res (2012) 0.78

6-Amino-1-benzyl-4-(4-chloro-phen-yl)-3-(4-pyrid-yl)-1,4-dihydro-pyrano[2,3-c]pyrazole-5-carbonitrile. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75